Found 69 matching trials
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
PHASE3The objective of the current study is to investigate the efficacy, safety a...
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Effects of Linagliptin on Endothelial Function
PHASE4This study is planned to evaluate if linagliptin can improve endothelial fu...
Location
Medical University of Graz, Department for Internal Medicine
Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes
PHASE2The objective of the study is to test the efficacy, safety and tolerability...
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
PHASE3The purpose of this research study is to evaluate the efficacy and safety o...
Location
Phoenix Children's Hospital
BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes
PHASE3The objective of the current study is to investigate the efficacy, safety a...
Location
1218.18.54001 Boehringer Ingelheim Investigational Site
The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
PHASE4This is a single center, prospective randomized double blind, parallel and ...
Location
ECMC Ambulatory Center, 3rd Floor
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
PHASE2The objective of this study is to investigate the effect of BI 1356 on 24-h...
Location
1218.37.49003 Boehringer Ingelheim Investigational Site
The Microvascular Function of GLP-1 and Its Analogues
NAIncretins have become a successful drug target in the repertoire of medicat...
Location
Diabetes and Vascular Center
Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose
PHASE2This study will test the effect of four common oral anti-diabetic agents on...
Location
Oslo University Hospital, Aker Hospital
HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
PHASE3The purpose of this study is to assess the efficacy of HSK7653 (as an add-o...
Location
Peking University People's Hospital